Study of the Clinical Efficacy of Autologous SCT in Patients With Critical Limb Ischemia
- Conditions
- Critical Limb Ischemia
- Registration Number
- NCT01311011
- Brief Summary
Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in patients with Critical Limb Ischemia
- Detailed Description
Phase II Prospective Study of the Clinical Efficacy of Autologous SCT in patients with Critical Limb Ischemia
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 26
Inclusion Criteria
- Patients with Critical Limb Ischemia
Exclusion Criteria
- Patients with other than Critical Limb Ischemia
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie autologous stem cell transplantation efficacy in CLI patients?
How does autologous SCT compare to standard revascularization therapies for CLI in clinical outcomes?
Which biomarkers correlate with improved perfusion after autologous SCT in CLI populations?
What adverse events are associated with autologous SCT in CLI and how are they managed?
Are there combination therapies with autologous SCT for CLI that enhance angiogenic potential?
Trial Locations
- Locations (1)
Kfsh & Rc
🇸🇦Riyadh, Saudi Arabia